Global Patient-controlled Analgesic Pumps Market by Application (Diabetes, Hematology, Gastroenterology, Oncology), by Type (Electronic, Mechanical) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast To 2028

Summary of the Report

Global patient-controlled analgesic pump market was valued at USD 292.4 Million in 2020. It is expected to grow at a compound annual rate (CAGR of 5.6%) between 2021 and 2028. Major factors driving this market are the increasing geriatric population, and the preference for more advanced surgical procedures that can be performed at home and in offices. Patient-controlled pumps offer several benefits over conventional modules. They allow for better patient management and care. The demand for patient-controlled analgesics (PCA) pumps will rise in the near future due to rising trends in Home Healthcare settings. The overall COVID19 effect on the global market resulted in a sharp decline in each year due to the limited number of surgeries performed during the second and third quarters 2020. As shown in the below bar graph, Japan's market will regain momentum in the second quarter 2021.

Globally, the prevalence of chronic diseases such as arthritis, cancer, and pain has seen a dramatic rise. Market growth will be boosted by the increasing number of people suffering from chronic pain. According to the Centers for Disease Control and Prevention, around 20.4% of Americans suffered from chronic pain in 2016, according to the CDC. Due to an increase in diabetes and a rise of cancer survival rates, chronic pain will likely increase over the next few years. Patients will be more in need of patient-controlled analgesic pump to relieve chronic pain.

Market progression will also be accelerated by rising cancer incidences around the world. According to the National Cancer Institute in the United States, there were approximately 1,806,590 new cases of cancer in 2020. The rising incidence of cancer has led to a greater demand for patient-controlled analgesic pump technology. These pumps are safe and effective in relieving pain associated with cancer.

Patients-controlled analgesic pumps can be used to manage pain after surgery. They are more reliable than frequent analgesic injections and offer consistent pain relief. The PCA pump allows patients to easily inject large amounts of narcotics into their veins by simply pressing the push button. This pump also helps to manage pain following surgery, which can speed up recovery. These pumps can also be used to reduce or eliminate the need for intramuscular shots. It has a lower rate of anxiety and better analgesic effects. Additionally, it is less likely to cause pulmonary complications than other analgesics. There are many benefits to PCA pumps, including increased patient satisfaction, pain relief, less postoperative complications and faster market growth.

Many patient-controlled analgesic pump options are available for pain management in a homecare setting, particularly during a pandemic. CME Medical's TPCA Patient Controlled Analgesia Syringe Pump can be used in both home care and hospitals, depending on the patient's requirements. These pumps can be used in ambulatory or bedside settings and are lightweight and compact. Market growth will be accelerated by the increasing demand for PCA pumps within home care settings.

Analgesic pumps that can be controlled by patients are effective for pain relief in a wide range of conditions, including acute post-operative pain management. The options for pain management have been expanded by the availability of novel patient-controlled analgesic methods such as PCRA, PCEA and noninvasive forms PCA. Infusions are calculated according to patient requirements and improved patient monitoring. These advances will increase the effectiveness of these treatments during the forecast timeframe.

The incorporation of the latest technology in PCA pumps speeds up pain recovery and increases patient preference, which in turn accelerates market growth. Acromed Chroma infusion pump integrates the most recent technology in pain management that allows patients to self administer bolus analgesic medication. This helps patients manage pain and makes them feel more comfortable, while also reducing the need for hospital staff to be present.

Type Insights

In 2020, 56.8% of the market share for patient-controlled analgesic pump sales went to electronic pumps. To control the infusion rate, an electronically patient-controlled analgesic pumps uses a single-chip microcomputer. Analgesic pumps that are electronically controlled for Patient-controlled Epidural Analgesia, or PCEA (patient-controlled epidural analgesia) can be used safely for childbirth and postoperative pain management. This increases the segment demand. Studies have also shown that electronic PCA pumps can be controlled based on the patient's requirements. There are still risks that electronic PCA pumps could make mistakes in PCA treatment. During the dosing phase, human and machine errors can occur that could affect the segmental growth during the analysis timeframe.

The second-largest segment is mechanical, with promising growth prospects. Patients and healthcare professionals are increasingly choosing to use mechanical patient-controlled analgesic pump systems. They have many advantages that make them attractive. The advantages of mechanical PCA pumps are their small size, portability, low cost, ease of use, and lack programming errors. Numerous studies have demonstrated that analgesic pumps with mechanical components have lower failure rates and higher patient satisfaction. This has increased their adoption rate.

End-use Insights

Hospitals dominated the market for patient controlled analgesic pumps in 2020, accounting for 31.5% of the total revenue. Hospitals are the most common place for patient-controlled analgesic therapy. The market is expected to grow because of the availability of many of the most advanced and sophisticated patient-controlled analgesic pump systems in hospitals. There is also a growing demand for advanced PCA pumps in new hospitals, especially in developing countries.

Home care settings will show the fastest expected CAGR during the forecast period. Homecare settings can prevent pain-related hospitalization, which will help secure its market growth. Homecare can offer pain management with patient-controlled analgesics using Computerized Ambulatory Drug Delivery Devices (CADD). Patients who are in hospice and have severe or moderate pain from cancer can use PCA pumps at their home to help them grow.

Application Insights

Oncology dominated the market for patient-controlled analgesic pump and was responsible for 30.6% of the total revenue in 2020. PCA pumps are used to control pain from cancer by administering intravenous opioids via a self-controlled pump. Individuals with moderate to severe pain due to cancer can use patient-controlled analgesic pump at home. Segmental growth will be accelerated by the increasing use of PCA pumps in home care settings to treat diabetes. Many hospitals and specialty clinics offer patient-controlled analgesic pumps to help with chronic pain. The market is expected to grow due to the growing number of specialty centers, hospitals, ambulatory surgery centers, and specialty clinics in both developed and developing countries offering pain management solutions for cancer patients.

From 2021 to 2028, the diabetes market is expected to grow at 6.4% CAGR. The PCA pumps can be used to reduce pain in diabetic patients. PCA pumps will continue to grow due to the increasing prevalence of diabetes around the world. According to the American Diabetes Association, 34.2 million Americans had diabetes in 2018. In the treatment of type-1 diabetes, patient-controlled analgesic pump are becoming more popular for pain control.

Regional Insights

North America was the dominant market for patient-controlled analgesic pump and had the largest revenue share, 40.0% in 2020. This region will continue to dominate the market for patient-controlled analgesic pumps over the forecast period. The market can be divided into North America and Latin America, Europe and Asia Pacific. The market for patient-controlled pain relief pumps is expected to grow due to rising incidences of cancer, diabetes, and other ailments related to pain management. This region is seeing a rise in geriatric populations and the increasing benefits of patient-controlled pain relief pumps.

Asia Pacific is expected to experience the fastest CAGR during the forecast period. Market expansion is expected to be boosted by rising awareness of new technologies, especially in India and China, as well as increasing prevalence of chronic diseases. Market growth is being driven by a growing geriatric population, better healthcare infrastructure, and increased awareness about pain management.

Market Share Insights & Key Companies

To maintain their market share, key players adopt a variety of strategies to keep it. These include product launches, strategic acquisitions and innovation. The following are some of the most prominent players in patient-controlled analgesics (PCA) pump market:

• Baxter International Inc.

• B. Braun Melsungen AG

• Smiths Group plc

• Fresenius SE & Co. KGaA

• Becton, Dickinson and Company

• ICU Medical

Up Market Research published a new report titled “Patient-controlled Analgesic Pumps Market research report which is segmented by Application (Diabetes, Hematology, Gastroenterology, Oncology), by Type (Electronic, Mechanical), By Players/Companies Fresenius SE & Co KGaA, ICU Medical, Smiths Group plc, Baxter International Inc, B Braun Melsungen AG, Becton Dickinson and Company”. As per the study the market is expected to grow at a CAGR of XX% in the forecast period.

Report Scope

The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.

Global Patient-controlled Analgesic Pumps Market Report Segments:

The market is segmented by Application (Diabetes, Hematology, Gastroenterology, Oncology), by Type (Electronic, Mechanical).

Patient-controlled Analgesic Pumps Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.

Key Benefits for Industry Participants & Stakeholders:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Patient-controlled Analgesic Pumps Market

Overview of the regional outlook of the Patient-controlled Analgesic Pumps Market:

Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.

Highlights of The Patient-controlled Analgesic Pumps Market Report:

1. The market structure and projections for the coming years.
2. Drivers, restraints, opportunities, and current trends of Patient-controlled Analgesic Pumps Market.
3. Historical data and forecast.
4. Estimations for the forecast period 2028.
5. Developments and trends in the market.

                1. Diabetes

                2. Hematology

                3. Gastroenterology

                4. Oncology

                1. Electronic

                2. Mechanical

8. Market scenario by region, sub-region, and country.
9. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
10. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
11. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Patient-controlled Analgesic Pumps Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.

How you may use our products:

• Correctly Positioning New Products
• Market Entry Strategies
• Business Expansion Strategies
• Consumer Insights
• Understanding Competition Scenario
• Product & Brand Management
• Channel & Customer Management
• Identifying Appropriate Advertising Appeals

Reasons to Purchase the Patient-controlled Analgesic Pumps Market Report:

• The report includes a plethora of information such as market dynamics scenario and opportunities during the forecast period
• Segments and sub-segments include quantitative, qualitative, value (USD Million,) and volume (Units Million) data.
• Regional, sub-regional, and country level data includes the demand and supply forces along with their influence on the market.
• The competitive landscape comprises share of key players, new developments, and strategies in the last three years.
• Comprehensive companies offering products, relevant financial information, recent developments, SWOT analysis, and strategies by these players.